Bart Haagmans is a virologist at the department of Viroscience of the Erasmus Medical Center in Rotterdam. He did his training at the Utrecht University and holds a PhD from the same university. His main interest is the pathogenesis of emerging viral infections, especially coronaviruses including SARS and MERS coronavirus. He is a recognized leader in the field of coronaviruses and was involved in the characterization of the MERS-CoV genome and development of molecular and serological assays to detect MERS-CoV. More recently, he was involved in studies to identify the receptor used by MERS-CoV to infect cells and studies that led to the identification of the intermediate host of MERS-CoV, the dromedary camel. Currently the focus of his research is the development of a MERS-CoV vaccine. In addition, he is actively involved in issues related to biosafety in laboratories but also during outbreaks caused by viruses such as MERS-CoV and ebola virus.